AQST Aquestive Therapeutics Inc
10,971
$3.19
$0.08
(2.57%)
| Watchers | 10,971 |
| 52-Wk Low | $1.25 |
| 52-Wk High | $6.23 |
| Market Cap | $290.41M |
| Volume | 656,397.00 |
| 52-Wk High | $6.23 |
| 52-Wk Low | $1.25 |
Aquestive Therapeutics (NASDAQ:AQST) Earns "Buy" Rating from HC WainwrightTicker Report • about 2 months ago
Aquestive Therapeutics (NASDAQ:AQST - Get Free Report)s stock had its "buy" rating reiterated by research analysts at HC Wainwright in a report released on Friday, Benzinga reports. They...
Share to Feed
Aquestive Therapeutics (AQST) has provided an update. Aquestive Therapeutics, Inc. has bolstered its Board of Directors with the addition of Abigai...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Appoints Abigail Abbey Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of DirectorsWARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE...
Raymond James initiated coverage on shares of Aquestive Therapeutics (NASDAQ:AQST - Free Report) in a research report report published on Thursday, MarketBeat Ratings reports. The firm issued an...
Analysts at Raymond James initiated coverage on shares of Aquestive Therapeutics (NASDAQ:AQST - Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat reports...
WARREN, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ( Aquestive or the Company ), a pharmaceutical company advancing medicines to bring meaningful...
This is a signal that AQST's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a Bearish indicator signaling AQST's price could decline from here. Traders may explore shorting the stock or put options...
This indicator may be signaling that AQST's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...